Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rare Diseases 2Polycystic Ovary Syndrome 2Obesity 2Hyperinsulinism 2Endocrine System Diseases 2Carcinoma, Renal Cell 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Prostatic Neoplasms 1Prediabetic State 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Mycosis Fungoides 1Mouth Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Li-Fraumeni Syndrome 1Leukoplakia, Oral 1

Interventions

Specimen Handling 2Endoscopy, Digestive System 2Endoscopy 2Biopsy 2Aspirin 2polyphenon E 1obeticholic acid 1Ursodeoxycholic Acid 1Radiofrequency Ablation 1Metformin 1Itraconazole 1Genetic Linkage 1Gastroscopy 1Esomeprazole 1Erlotinib Hydrochloride 1Comparative Genomic Hybridization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Barrett Esophagus × Metformin × Clear all
NCT01447927 2014-07-21

Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 2 Completed
93 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡